Bleichmar Fonti & Auld LLP is investigating Coastal Financial Corporation for potential securities fraud related to its banking as a service segment and CCBX partner relationships. The probe follows a sharp 43.5% stock drop on July 30, 2026, after Coastal Financial reported a $42.1 million quarterly net loss, driven by a $68.8 million credit expense linked to an unnamed CCBX partner. Investors who bought Coastal Financial securities are encouraged to seek legal advice as the investigation unfolds, with no upfront costs for representation. This case highlights risks in the banking as a service sector and could impact shareholder confidence further.
Nyxoah announced preliminary Q3 2026 revenue of €9.2 million, up 19% sequentially, driven by a 29% increase in U.S. sales. The company submitted a PMA supplement to the FDA to expand its Genio device indication for patients with complete concentric c...
ASML Holding N.V. announced recent transactions under its ongoing share buyback program, repurchasing a total of 233,867 shares between October 12 and October 16, 2026. The shares were bought back at weighted average prices ranging from €1,444.83 to ...
The Phase 3 ALKIVIA trial demonstrated that efgartigimod significantly improves symptoms in patients with autoimmune myositis, including immune-mediated necrotizing myopathy (IMNM) and dermatomyositis (DM). Patients showed meaningful clinical improve...
In 2025, Berkshire Hathaway, led by Greg Abel, received $479 million in dividends from its $1.3 billion investment in American Express. This highlights the value of holding strong dividend-paying stocks for steady income. Retail investors can apply s...
Lexeo Therapeutics announced an educational event on October 21, 2026, focusing on clinical endpoints and outcome measures in PKP2 arrhythmogenic cardiomyopathy (PKP2-ACM). The event will feature discussions by Lexeo's Chief Medical Officer and a lea...
